Editorial |

Melatonin Therapy: From Benzodiazepine-Dependent Insomnia to Authenticity and Autonomy

Harold J. Bursztajn, MD
Arch Intern Med. 1999;159(20):2393-2395. doi:10.1001/archinte.159.20.2393.
Text Size: A A A
Published online


FOR PATIENTS for whom the potential short-term benefits of insomnia relief by benzodiazepine therapy are offset by their specific vulnerability to both acute and long-term adverse effects or dependency, the study by Garfinkel and colleagues1 using melatonin therapy for discontinuation offers a hopeful adjunct in the weaning process and a sleep-maintenance alternative to benzodiazepine therapy. Alternatives such as melatonin therapy can be also helpful in maintaining a therapeutic alliance by offering a treatment enabling focus instead of a do-or-die crisislike atmosphere that can surround the encounter between a concerned clinician and a vulnerable, anxious patient seeking or already dependent on benzodiazepines. Thus, for clinicians who treat patients who are benzodiazepine-dependent and suffer from insomnia, an informed consent process that offers melatonin therapy as an alternative to benzodiazepine dependence integrates good clinical care with effective risk management by carefully navigating between the Scylla of addiction and the Charybdis of abandonment.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 2

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Main neuroendocrine features and therapy in primary sleep troubles. Rev Med Chir Soc Med Nat Iasi 2012 Jul-Sep;116(3):862-6.